A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
about
Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaGenetic alterations in hepatocellular carcinoma: An updateMicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells.
P2860
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
@en
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells.
@nl
type
label
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
@en
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells.
@nl
prefLabel
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
@en
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells.
@nl
P2093
P2860
P50
P1433
P1476
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
@en
P2093
Antonella Cusimano
Giuseppa Augello
Maria Rita Emma
P2860
P304
P356
10.1080/15384101.2016.1138183
P577
2016-01-21T00:00:00Z